MedCap
MedCap AB is a Swedish medical technology investment group acquiring and developing niche life science and healthcare companies across Northern Europe. The company operates through three business segments: Medical Technology, manufacturing specialized assistive devices, Specialist Pharmaceuticals, distributing niche prescription drugs, and Assistive Tech. Revenue is derived from product sales of medical devices, niche pharmaceutical distribution, and technical healthcare equipment sales across its portfolio subsidiaries. Core end markets serve hospitals, rehabilitation centers, pharmacies, elderly care providers, and public healthcare authorities across the Nordics and Europe. MedCap holds a leading position in the Nordic healthcare sector as a specialized buy-and-build investor in medical technology and niche pharmaceuticals. The company is headquartered in Stockholm, Sweden, and its ordinary shares trade on the Nasdaq Stockholm exchange.
20 of the funds FundTelligence covers report a position in MedCap.
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 20
Funds holding MedCap
- PriorNilsson Evolve Global — PriorNilsson · 6.29 % (full portfolio disclosed, June 2026)
- Cliens Micro Cap — Cliens · 6.2 % (largest positions only, October 2026)
- Spiltan Småbolagsfond — Spiltan Fonder · 5.2 % (full portfolio disclosed, June 2026)
- PriorNilsson Småbolag — PriorNilsson · 4.89 % (full portfolio disclosed, June 2026)
- Case Gaia Microcap — Case · 3.82 % (full portfolio disclosed, June 2026)
- Pareto Småbolagsfond — Pareto · 3.0 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 2.83 % (full portfolio disclosed, June 2026)
- ODIN Small Cap — ODIN · 2.26 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 20 funds holding it.